Evidence map›Paper›PMID 31164115›Full record

Observational studyBMC palliative care2019

A prospective study examining cachexia predictors in patients with incurable cancer.

Ola Magne Vagnildhaug, Cinzia Brunelli, Marianne J Hjermstad, Florian Strasser, Vickie Baracos, Andrew Wilcock, Maria Nabal, Stein Kaasa, Barry Laird, Tora S Solheim

Registry-linked trialOpen access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in BMC palliative care, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01362816 (The European Palliative Care Cancer Symptom Study), which is not on this map. Cited by 18 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 3 pooled it
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01362816 completednot on this map

The European Palliative Care Cancer Symptom Study (EPCCS). A Prospective Data Collection

TypeobservationalSponsorNorwegian University of Science and TechnologyRan2011 to 2013Enrolled1,739ConditionsCancer
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 3 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Cancer cachexia as a multiorgan failure: Reconstruction of the crime scene.Frontiers in cell and developmental biology · 2022
    Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 6 countries.

Ola Magne VagnildhaugDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Postbox 8905 MTFS, NO-7491, Trondheim, Norway. ola.m.vagnildhaug@ntnu.no.ORCID http://orcid.org/0000-0001-9419-5969
Cinzia BrunelliPalliative Care, Pain Therapy and Rehabilitation Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, via Giacomo Venezian 1, 20133, Milan, Italy.
Marianne J HjermstadEuropean Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Box 4956, Nydalen, 0424, Oslo, Norway.
Florian StrasserDepartment of Internal Medicine and Palliative Care Centre, Cantonal Hospital, Oncological Palliative Medicine, Section Oncology, Rorschacher Strasse 95, CH-9007, St. Gallen, Switzerland.
Vickie BaracosDivision of Palliative Care Medicine, Department of Oncology, University of Alberta, Cross Cancer Institute 11560 University Avenue, Edmonton, Alberta, T6G 1Z2, Canada.
Andrew WilcockNottingham University Hospitals NHS Trust, Hucknall Road, Nottingham, NG5 1PB, UK.
Maria NabalHospital Universitari Arnau de Vilanova and Universidad de Lleida, Av. Alcalde Rovira Roure 80, 25198, Lleida, Spain.
Stein KaasaEuropean Palliative Care Research Centre (PRC), Department of Oncology, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Box 4956, Nydalen, 0424, Oslo, Norway.
Barry LairdEdinburgh Cancer Research UK Centre, University of Edinburgh, Western General Hospital, Crewe Road South, Edinburgh, EH4 2XR, UK.
Tora S SolheimDepartment of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU - Norwegian University of Science and Technology, Postbox 8905 MTFS, NO-7491, Trondheim, Norway.
Oslo University Hospital · NONorwegian University of Science and Technology · NOHospital Universitari Arnau de Vilanova · ESKantonsspital St. Gallen · CHNottingham University Hospitals NHS Trust · GBUniversity of Alberta · CAWestern General Hospital · GB

Funding

Helse Midt-Norge 6070Helsinn NAKreftforeningen NAMarie Curie MCCC-RP-16-A20997
6 · The paper itself

Abstract

backgroundEarly intervention against cachexia necessitates a predictive model. The aims of this study were to identify predictors of cachexia development and to create and evaluate accuracy of a predictive model based on these predictors.

methodsA secondary analysis of a prospective, observational, multicentre study was conducted. Patients, who attended a palliative care programme, had incurable cancer and did not have cachexia at baseline, were amenable to the analysis. Cachexia was defined as weight loss (WL) > 5% (6 months) or WL > 2% and body mass index< 20 kg/m

resultsSix-hundred-twenty-eight patients were included in the analysis. Median age was 65 years (IQR 17), 359(57%) were female and median Karnofsky performance status was 70(IQR 10). Median follow-up was 109 days (IQR 108), and 159 (25%) patients developed cachexia. Initial WL, cancer type, appetite and chronic obstructive pulmonary disease were significant predictors (p ≤ 0.04). A five-level model was created with each level carrying an increasing risk of cachexia development. For Risk-level 1-patients (WL < 3%, breast or hematologic cancer and no or little appetite loss), median time to cachexia development was not reached, while Risk-level 5-patients (WL 3-5%) had a median time to cachexia development of 51 days. Accuracy of cachexia predictions at 3 months was 76%.

conclusionImportant predictors of cachexia have been identified and used to construct a predictive model of cancer cachexia.

trial registrationClinicalTrials.gov Identifier: NCT01362816 .

Indexed as

AgedAged, 80 and overCachexiaFemaleHumansMaleNeoplasmsNutritional StatusProportional Hazards ModelsProspective StudiesSex FactorsWeight LossCachexiaCancerPalliative carePre-cachexiaWeight loss

Identifiers

PMID31164115
PMCPMC6549342
OpenAlexW2948069685

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.